Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 115M 99.08M 92.9M 84.8M 160M 10.99B 160M 1.1B 430M 5.55B 432M 422M 18.39B | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 106M 91.22M 85.53M 78.07M 147M 10.12B 148M 1.01B 396M 5.11B 397M 389M 16.93B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
94.39% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 115M | ||
| -0.78% | -1.42% | +2.96% | +21.65% | 50.47B | ||
| -6.00% | -0.75% | +447.48% | +535.14% | 44.56B | ||
| -0.24% | +0.74% | +37.18% | +16.26% | 43.08B | ||
| -1.55% | -2.07% | +19.83% | +71.70% | 41.7B | ||
| -0.31% | -0.83% | +19.47% | +48.24% | 33.21B | ||
| -1.79% | -3.24% | +26.32% | +125.06% | 16.77B | ||
| -0.58% | -2.12% | - | - | 16.28B | ||
| -0.88% | -0.66% | +11.63% | +27.62% | 14.58B | ||
| -1.66% | -1.25% | +78.49% | +42.97% | 13.92B | ||
| Average | -2.13% | -1.06% | +80.42% | +111.08% | 30.51B | |
| Weighted average by Cap. | -1.70% | -1.06% | +96.28% | +129.03% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.62M 1.4M 1.31M 1.2M 2.26M 155M 2.26M 15.56M 6.07M 78.34M 6.1M 5.96M 260M | 125K 108K 101K 92.4K 174K 11.97M 175K 1.2M 469K 6.04M 470K 460K 20.04M |
| Net income | -12.66M -10.91M -10.23M -9.34M -17.6M -1.21B -17.65M -121M -47.36M -611M -47.55M -46.51M -2.03B | -233M -201M -188M -172M -324M -22.28B -325M -2.23B -872M -11.25B -875M -856M -37.29B |
| Net Debt | 1.4M 1.2M 1.13M 1.03M 1.94M 133M 1.95M 13.38M 5.22M 67.37M 5.24M 5.13M 223M | -9.12M -7.86M -7.37M -6.73M -12.68M -872M -12.72M -87.46M -34.13M -440M -34.26M -33.51M -1.46B |
Employees
-
















